The Podcast Production Team at HG Media has just produced another episode of Medical Insights with Dr. Thomas Blom featuring his guest Dr. Sheetal Shrimanker.
In this episode of Medical Insights, Dr. Thomas Blom interviews Dr. Sheetal Shrimanker, a hematologist-oncologist at Penn Medicine, to help demystify complex plasma cell disorders. Together, they explore the critical differences between benign conditions like MGUS and active Multiple Myeloma, outlining how physicians utilize modern staging and the CRAB criteria to assess patient risk. The discussion also highlights both current treatment pathways — such as induction therapy and stem cell transplants — and the promising future of care, including cutting-edge CAR T-cell therapy and bi-specific antibodies.
This episode was produced by the Podcast Production Team at HG Media and is available on Apple Podcasts, Spotify, or wherever you listen to podcasts.
